Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiangpu Zhengqi
- Development stage
- Unknown
- Lead developer
- Guangzhou University of Chinese Medicine Science and Technology Industrial Park
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Xiangpu Zhengqi is a Traditional Chinese Medicine (TCM) formulation developed by Guangzhou University of Chinese Medicine Science and Technology Industrial Park Co., Ltd., primarily indicated for the treatment of the common cold, specifically the summer heat-dampness type. The formula is a modern preparation of the classic Xiangru Zhengqi (香薷正气) prescription, which traditionally combines *Mosla chinensis* (Xiangru), *Magnolia officinalis* (Houpo), and *Lablab purpureus* (Baibiandou). Its pharmacological profile includes antipyretic, anti-inflammatory, and gastrointestinal regulatory activities, aimed at alleviating symptoms such as fever, headache, nausea, and diarrhea associated with summer seasonal infections. It is typically formulated as an oral liquid for improved bioavailability and ease of administration.
- Brand names
- Xiangpu Zhengqi
- Other names
- Xiangru ZhengqiXiang Ru Zheng QiXiang Pu Zheng QiXiangru Zhengqi Oral Liquid
Beyond the preview
Go deeper on Xiangpu Zhengqi.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xiangpu Zhengqi.